• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Medtronic Points Up, but Wait for More Strength to Buy

The technical indicators are mixed for the big medical device maker and suggest bulls are not strongly behind the latest advance in the shares.
By BRUCE KAMICH
Jan 12, 2021 | 08:13 AM EST
Stocks quotes in this article: MDT

In his first Executive Decision segment of his "Mad Money" show Monday, host Jim Cramer spoke with Geoff Martha, chairman and CEO of medical device maker Medtronic (MDT)  , which has seen its shares under pressure during the pandemic despite a pent-up demand for electric medical procedures.

Martha said Medtronic has moved beyond simple devices and is now implanting real computers inside of patients. These advanced therapies require a lot of work and capital, he said, which is why Medtronic has increased its research and development. It also has levered its balance sheet, making seven recent acquisitions.

Let's check out Medtronic's charts and technical indicators. The last time we looked at MDT was Oct. 15; at that time we wrote, "When we looked at MDT back on May 18, we wrote 'MDT is in no man's land -- too far above where I would risk (below $90) and too far below a breakout point to give me confidence.' Prices weakened into late June. Today I see prices are higher than back in May but the indicators are just not in gear with a bullish recommendation. I would look for some sideways to lower price action in the weeks ahead."

In this updated daily Japanese candlestick chart of MDT, below, we can see that prices declined in the back half of October and into early November. Prices gapped higher in November and continued to rally to new highs. Today we can see a mixed picture with prices in an uptrend above the rising 50-day and rising 200-day moving averages. The On-Balance-Volume (OBV) line did not bottom out until December and its subsequent advance has not taken the OBV line to new highs like prices have done. This is a bearish divergence. The Moving Average Convergence Divergence (MACD) oscillator has turned upward in recent weeks to signal a fresh outright buy signal. We'll see how long this lasts as the moving averages are narrowing already.

In this weekly Japanese candlestick chart of MDT, below, we can see that prices are retesting the highs of 2020. Prices are in an uptrend above the rising 40-week moving average line. The weekly OBV line shows improvement from March but it is still below its peak of 2020. The 12-week price momentum study in the lower panel shows that the pace of the advance has begun to slow.

In this daily Point and Figure chart of MDT, below, we can see a double-top breakout in November (look for the letter "B") and a potential price target in the $156 area.

Bottom line strategy: The daily Point and Figure chart ignores volume and it is bullish, but our other two charts that show the OBV line suggest the bulls are not strongly behind the current advance. Traders should wait for strength above $120 before probing the long side. Risk below $115. The $156 area is the price target for 2021.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Life Sciences | Technology | Mad Money | Executive Interview | Real Money

More from Stocks

Hungry Traders and Stock Opportunities Aren't Likely to Go Away Soon

James "Rev Shark" DePorre
Jan 15, 2021 4:40 PM EST

It doesn't take much time for stocks with strong momentum to reset and continue on their way.

At What Price Is Ballard Power Systems a Buy?

Bruce Kamich
Jan 15, 2021 3:09 PM EST

Let's check out the latest charts of BLDP.

United Parcel Service Is Testing Key Support

Bruce Kamich
Jan 15, 2021 2:30 PM EST

A look at the charts of UPS.

A Buy and Hold Play With Hennessy Capital V

Timothy Collins
Jan 15, 2021 2:24 PM EST

HCICU hit the public markets today.

Jim Cramer: It's High Time to Call in the Covid Assassins

Jim Cramer
Jan 15, 2021 2:00 PM EST

Enroll the private sector that has the capability of vaccinating en masse and save the kingdom.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:01 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    When it's time to sell, will you act or freeze?
  • 08:35 AM EST GARY BERMAN

    Wednesday Morning Fibocall for 1/13/2021

    Lower highs... SPX (Long-Term View) The 1/8/2...
  • 08:07 AM EST GARY BERMAN

    Tuesday Morning Fibocall for 1/12/2021

    Watch if the recent trend of lower highs continues...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login